Coronary Atherosclerotic Plaque Activity and Future Coronary Events.
暂无分享,去创建一个
E. V. van Beek | S. Lewis | D. Dey | P. Slomka | M. Dweck | D. Newby | J. Greenwood | D. Dawson | N. Mills | A. Fletcher | J. Rudd | P. Calvert | J. Kwiecinski | A. Moss | J. Verjans | M. Daghem | E. Tzolos | M. Meah | P. Arumugam | N. Sabharwal | A. Bularga | M. Williams | Kang-Ling Wang | P. Adamson | J. Townend | Robert J Lee | D. Berman | Laura Forsyth | Lauren Murdoch | S. Lewis | M. Williams
[1] M. Hacker,et al. In Vivo Coronary 18F-Sodium Fluoride Activity: Correlations With Coronary Plaque Histological Vulnerability and Physiological Environment. , 2022, JACC. Cardiovascular imaging.
[2] G. Feuchtner,et al. CT or Invasive Coronary Angiography in Stable Chest Pain. , 2022, The New England journal of medicine.
[3] J. Peper,et al. External validation of the GRACE risk score and the risk–treatment paradox in patients with acute coronary syndrome , 2022, Open Heart.
[4] E. V. van Beek,et al. Thoracic Aortic 18F-Sodium Fluoride Activity and Ischemic Stroke in Patients With Established Cardiovascular Disease , 2022, JACC. Cardiovascular imaging.
[5] G. Hillis,et al. Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome. , 2020, Atherosclerosis.
[6] G. Watts,et al. 18F-Sodium Fluoride Positron Emission Tomography Activity Predicts the Development of New Coronary Artery Calcifications , 2020, Arteriosclerosis, thrombosis, and vascular biology.
[7] E. V. van Beek,et al. Coronary 18F-Fluoride Uptake and Progression of Coronary Artery Calcification , 2020, Circulation. Cardiovascular imaging.
[8] J. Leipsic,et al. Ex vivo 18F-fluoride uptake and hydroxyapatite deposition in human coronary atherosclerosis , 2020, Scientific Reports.
[9] Deepak L. Bhatt,et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.
[10] D. Dey,et al. Respiration-averaged CT versus standard CT attenuation map for correction of 18F-sodium fluoride uptake in coronary atherosclerotic lesions on hybrid PET/CT , 2020, Journal of Nuclear Cardiology.
[11] D. Dey,et al. Observer repeatability and interscan reproducibility of 18F-sodium fluoride coronary microcalcification activity , 2020, Journal of Nuclear Cardiology.
[12] D. Newby,et al. Clinical endpoint adjudication , 2020, The Lancet.
[13] E. V. van Beek,et al. Coronary 18F-Sodium Fluoride Uptake Predicts Outcomes in Patients With Coronary Artery Disease. , 2020, Journal of the American College of Cardiology.
[14] D. Dey,et al. Whole-vessel coronary 18F-sodium fluoride PET for assessment of the global coronary microcalcification burden , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[15] F. Lin,et al. 18F-NaF PET/CT in Ex Vivo Human Coronary Arteries With Histological Correlation. , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[16] Habib Samady,et al. Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study , 2019, The Lancet.
[17] V. Fuster,et al. From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.
[18] Á. Avezum,et al. Complete Revascularization with Multivessel PCI for Myocardial Infarction. , 2019, The New England journal of medicine.
[19] Joshua D. Hutcheson,et al. 18F-Fluoride Signal Amplification Identifies Microcalcifications Associated With Atherosclerotic Plaque Instability in Positron Emission Tomography/Computed Tomography Images , 2019, Circulation. Cardiovascular imaging.
[20] D. Dey,et al. Feasibility of Coronary 18F-Sodium Fluoride Positron-Emission Tomography Assessment With the Utilization of Previously Acquired Computed Tomography Angiography , 2018, Circulation. Cardiovascular imaging.
[21] D. Dey,et al. Optimization of reconstruction and quantification of motion-corrected coronary PET-CT , 2018, Journal of Nuclear Cardiology.
[22] T. Akasaka,et al. Clinical Relevance of 18F-Sodium Fluoride Positron-Emission Tomography in Noninvasive Identification of High-Risk Plaque in Patients With Coronary Artery Disease , 2017, Circulation. Cardiovascular imaging.
[23] W. Ouwehand,et al. Detection of Atherosclerotic Inflammation by 68Ga-DOTATATE PET Compared to [18F]FDG PET Imaging , 2017, Journal of the American College of Cardiology.
[24] L. Trinquart,et al. Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates. , 2016, The Cochrane database of systematic reviews.
[25] Damini Dey,et al. Motion Correction of 18F-NaF PET for Imaging Coronary Atherosclerotic Plaques , 2016, The Journal of Nuclear Medicine.
[26] E. Warburton,et al. Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography , 2015, Nature Communications.
[27] M. Dweck,et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial , 2014, The Lancet.
[28] Giuseppe Biondi-Zoccai,et al. TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. , 2012, Contemporary clinical trials.
[29] E. V. van Beek,et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. , 2012, Journal of the American College of Cardiology.
[30] G. Raff,et al. SCCT guidelines on radiation dose and dose-optimization strategies in cardiovascular CT. , 2011, Journal of cardiovascular computed tomography.
[31] Akiko Maehara,et al. A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.
[32] F. Van de Werf,et al. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). , 2010, European heart journal.
[33] Michael G. Stabin,et al. SNM Practice Guideline for Sodium 18F-Fluoride PET/CT Bone Scans 1.0* , 2010, The Journal of Nuclear Medicine.
[34] Hirofumi Anno,et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. , 2009, Journal of the American College of Cardiology.
[35] Á. Avezum,et al. Predictors of hospital mortality in the global registry of acute coronary events. , 2003, Archives of internal medicine.
[36] OUP accepted manuscript , 2021, European Heart Journal - Cardiovascular Imaging.
[37] K. Murugiah,et al. Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China , 2020, Heart.
[38] D. Dey,et al. Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography. , 2019, European heart journal cardiovascular Imaging.
[39] T. Ichida,et al. World Medical Association declaration of Helsinki , 2008, Gastroenterologia Japonica.